SCHEMBL14970882

SCHEMBL14970882

O=C(Nc1nnc(COc2ccc(Cl)cc2)s1)c1ccncc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.72
ALDH1A1 P00352 8/20 0.71
MAPT P10636 6/20 0.71
HPGD P15428 6/20 0.71
HSD17B10 Q99714 4/20 0.71
ALOX15 P16050 3/20 0.71
L3MBTL1 Q9Y468 1/20 0.69
SMN1; SMN2 Q16637 2/20 0.69
NPC1 O15118 1/20 0.69
RAB9A P51151 1/20 0.69
KDM4E B2RXH2 2/20 0.65
TDP1 Q9NUW8 1/20 0.65
GAA P10253 3/20 0.61
LMNA P02545 3/20 0.61
RXFP1 Q9HBX9 1/20 0.60
GLA P06280 1/20 0.58
MEN1 O00255 2/20 0.58
POLB P06746 1/20 0.58
APOBEC3G Q9HC16 1/20 0.58
ABL1 P00519 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16080088 0.86 RAB9A (0.62) KMT2AALDH1A1MAPTHPGDHSD17B10
SCHEMBL3467903 0.84 KMT2A (0.69) KMT2AALDH1A1MAPTHPGDHSD17B10
SCHEMBL14966349 0.82 RAB9A (1.00) KMT2AALDH1A1MAPTHPGDHSD17B10
SCHEMBL25153579 0.79 ALDH1A1 (0.64) KMT2AALDH1A1MAPTHPGDHSD17B10
SCHEMBL29574976 0.79 L3MBTL1 (0.66) KMT2AL3MBTL1SMN1; SMN2RAB9AKDM4E
SCHEMBL3466732 0.79 NPC1 (0.72) KMT2AALDH1A1MAPTHPGDHSD17B10
SCHEMBL2181677 0.77 RAB9A (0.69) KMT2AALDH1A1MAPTHPGDHSD17B10
SCHEMBL30282647 0.76 POLQ (0.73) KMT2AALDH1A1MAPTHPGDHSD17B10
SCHEMBL25153665 0.76 POLQ (0.73) KMT2AALDH1A1MAPTHPGDHSD17B10
SCHEMBL3728312 0.76 KMT2A (0.58) KMT2AALDH1A1MAPTHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140275224-A1 CYTOSINE DEAMINASE MODULATORS FOR ENHANCEMENT OF DNA TRANSFECTION REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2014-09-18 US disclosed
US-20140275224-A1 CYTOSINE DEAMINASE MODULATORS FOR ENHANCEMENT OF DNA TRANSFECTION REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2014-09-18 US disclosed
WO-2013074059-A2 CYTOSINE DEAMINASE MODULATORS FOR ENHANCEMENT OF DNA TRANSFECTION REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2013-05-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140275224-A1 CYTOSINE DEAMINASE MODULATORS FOR ENHANCEMENT OF DNA TRANSFECTION CDA, DCTD, ADA KMT2A 1471/4885ALDH1A1 2191/4885MAPT 4829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.